Cargando…

Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. The landscape of the systemic treatment for advanced HCC is changing quickly, and recently, the standard of care became either atezolizumab plus bevacizumab or tremelimumab plus durvalumab in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Wilde, Nika, Vonghia, Luisa, Francque, Sven, De Somer, Thomas, Bagdadi, Ali, Staub, Eva, Lambrechts, Jasper, Bucalau, Ana-Maria, Verset, Gontran, Van Steenkiste, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453466/ https://www.ncbi.nlm.nih.gov/pubmed/36157862 http://dx.doi.org/10.4254/wjh.v14.i8.1608

Ejemplares similares

In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?
por: Bucalau, Ana-Maria, et al.
Publicado: (2021)

Duodenal Hemorrhage Due to an Invasive Hepatocellular Carcinoma Controlled by Transarterial Embolization
por: Deforche, Maxime, et al.
Publicado: (2022)

Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes
por: Bucalau, Ana-Maria, et al.
Publicado: (2020)

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Epidemiology and treatment of autoimmune hepatitis
por: Francque, Sven, et al.
Publicado: (2012)

Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
por: Van Herck, Mikhaïl A., et al.
Publicado: (2017)

Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
por: Vonghia, Luisa, et al.
Publicado: (2019)

Clinical impact of (99m)Tc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients
por: Bucalau, Ana-Maria, et al.
Publicado: (2023)

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015)

Difficult Diagnosis
Publicado: (1890)

Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
por: Gannichida, Ako, et al.
Publicado: (2022)

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry
por: de Baere, Thierry, et al.
Publicado: (2020)

Transarterial Chemoembolization with Anthracyclines-Loaded Polyethylene Glycol Drug Eluting Microspheres for the Treatment of Hepatocellular Carcinoma: A Pooled Multicentric Analysis of Survival in 580 Patients
por: Veloso Gomes, Filipe, et al.
Publicado: (2023)

Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD
por: van der Graaff, Denise, et al.
Publicado: (2021)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019)

Predictors of difficult endoscopic resection of submucosal tumors originating from the muscularis propria layer at the esophagogastric junction
por: Wang, Yu-Ping, et al.
Publicado: (2022)

CD4+RORγt++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2015)

Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis
por: Golfieri, Rita, et al.
Publicado: (2021)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Development of a prognostic scoring system for resectable hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2016)

Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
por: Wang, Dong-Xu, et al.
Publicado: (2020)

Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
por: Li, Daneng, et al.
Publicado: (2023)

Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
por: Appel-da-Silva, Marcelo Campos, et al.
Publicado: (2016)

Viral hepatitis and hepatocellular carcinoma
por: Michielsen, Peter P, et al.
Publicado: (2005)

Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective
por: Li, James Weiquan, et al.
Publicado: (2017)

Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
por: Wu, Wen-Chi, et al.
Publicado: (2022)

Adoptive Cell Transfer of Regulatory T Cells Exacerbates Hepatic Steatosis in High-Fat High-Fructose Diet-Fed Mice
por: Van Herck, Mikhaïl A., et al.
Publicado: (2020)

Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Cai, Yi, et al.
Publicado: (2020)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

A disease that is difficult to diagnose and treat: evaluation of 343 spondylodiscitis cases
por: Kaya, Safak, et al.
Publicado: (2021)

Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
por: Wang, Jian-Ping, et al.
Publicado: (2020)

Prognostic model of hepatocellular carcinoma based on cancer grade
por: Zhang, Guo-Xin, et al.
Publicado: (2023)

Radiofrequency ablation vs surgical resection in elderly patients with hepatocellular carcinoma in Milan criteria
por: Conticchio, Maria, et al.
Publicado: (2021)

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study
por: Verset, G, et al.
Publicado: (2007)

Liver resection vs radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients
por: Delvecchio, Antonella, et al.
Publicado: (2021)

Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
por: Conticchio, Maria, et al.
Publicado: (2023)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
por: Li, You-Cai, et al.
Publicado: (2018)

Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma
por: Yoon, Jae H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vaeecuj1s02cffqfcpc7rp33er